Funding

Parkinson's disease
#Charity #Funding #IRLAB Therapeutics #Parkinson's #The Michael J Fox Foundation

Parkinson’s charity awards $2m to support apathy treatment

Swedish company IRLAB Therapeutics has been awarded funding of over $2 million from The Michael J Fox Foundation for Parkinson’s Research (MJFF). The grant will be used to conduct a Phase I clinical study of IRL757, a drug candidate in development as a novel treatment of… Read More

#News

Dr Maud Dumoux, the Franklin, and Dr Victor Bolanos-Garcia, Oxford Target Therapeutics.
#Breast cancer #Funding #Oncology #Oxford Target Therapeutics #Rosalind Franklin Institute

Cancer drug discovery company wins £50K research residency

Oxford Target Therapeutics, a company developing a promising therapy for triple negative breast cancer, is one of three UK life science companies awarded research prizes by the Rosalind Franklin Institute, based in Oxfordshire, UK. The prizes, awarded in collaboration with the Science and Technology Facilities Council… Read More

#News

#Contract Research Organisations (CROs) #Financing #Funding #Metrion Biosciences

Ion-channel specialist CRO closes £3.7m in new equity financing

Metrion Biosciences has secured £3.5m ($4.4m) in new equity financing, which will be used to further expand the company’s laboratories in Cambridge, UK, invest in specialist equipment and enhance global marketing activities. The investment includes £2.5m from lead investor Maven Capital Partners and £1 million Gresham House Ventures. Metrion also… Read More

#Business & Investment #News

Doctor prepares vaccine
#Funding #Immunology #Immunology / Virology & Vaccines #Pandemic prevention #University of Oxford

University of Oxford receives £7.8 million to fight pandemic threats

The Oxford Vaccine Group (OVG), which led the development of the Oxford vaccine for Covid-19, has been awarded a total of £7.8 ($9.8) million by UK Aid for research into the prevention of five diseases with epidemic or pandemic potential. The awards will fund research into… Read More

#News

Vaccine development
#Bill & Melinda Gates Foundation #Funding #Immunology / Virology & Vaccines #Naobios #Omicron

Naobios receives $1.87 million in support of vaccine development 

Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based products, has received a $1.87 million grant from the Bill & Melinda Gates Foundation in support of vaccine development.   Naobios will manufacture a human viral challenge agent that will be used to evaluate… Read More

#News

#Eligo Bioscience #Funding #Gene editing #Genetics / genomics #Microbiome

Eligo raises $30 million to further gene editing within the microbiome

Gene editing company Eligo Bioscience has announced a successful $30 million Series B funding round, led by Sanofi Ventures. “We are excited to lead this financing for Eligo and support the company as they move to the clinic,” said Laia Crespo, Partner at Sanofi Ventures. “We are impressed by the… Read More

#Business & Investment #News

Bacteria
#Antibiotics #Antimicrobial resistance (AMR) #Funding #Glox Therapeutics #University of Glasgow #University of Oxford

University spin-out secures £4.3M to develop precision antibiotics

Glox Therapeutics has raised £4.3M ($5.2M) in seed funding to develop targeted therapeutics against antibiotic-resistant Gram-negative bacteria. The company will use the funding to establish laboratories in Oxford and Glasgow and expand its team to accelerate its bacteriocin development programme. Glox Therapeutics is developing precision antibiotics using engineered protein bacteriocins. Read More

#Business & Investment #News #Trending News

Petri dish used for bacterial research
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials #Funding

£30m initiative will support early-stage antimicrobial development

A partnership has been set up to promote the development of new treatments to tackle the global threat of antimicrobial resistance (AMR). Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 ($36) million initiative… Read More

#News #Trending News

Quantum computer
#Drug discovery #Funding #Quantum computing #Start-ups #Wellcome Trust

French start-ups win $40M for quantum drug discovery project

French start-ups Pasqal and Qubit Pharmaceuticals are among the 12 selected performers for the Quantum for Bio programme in consortium with the Unitary Fund. Together with the Unitary Fund, Pasqal and Qubit will receive $4.5 million of the total $40 million awarded through the various milestones under the Quantum for… Read More

#Business & Investment #News #Start-up Zone

#Biotechnology #Funding #Immunology / Virology & Vaccines #MinervaX

Funding to advance maternal vaccine against streptococcus 

MinervaX, a Danish biotechnology company developing a novel, prophylactic vaccine against Group B streptococcus (GBS), has announced the completion of €54 million upsized financing.   GBS is a leading cause of life-threatening infections in newborns as well as adverse pregnancy outcomes such as preterm delivery and stillbirths. Read More

#News

CRISPR gene editing
#CRISPR #Funding #Genetics / genomics #National Institutes of Health (NIH) #Neuroscience #Yale University

NIH awards ‘bench-to-bedside’ grant for CRISPR drug development

The National Institutes of Health has awarded the first phase of a roughly $40m grant to Yale University to advance a novel CRISPR-based gene-editing delivery platform for the targeted treatment of neurogenetic diseases. The two diseases being targeted in the project are Angelman syndrome and H1-4… Read More

#News

EU flag
#Cancer Research UK #Drug research #Funding #Horizon Europe #Investment #UK

What’s on the horizon for UK drug discovery?

Editor Reece Armstrong provides an introduction to the Fall 2023 issue of Drug Discovery World. Find out more about the issue and how to read it. That this issue should feature a market report on the state of the United Kingdom’s drug discovery sector at the same time the country… Read More

#Exclusive Content #Opinion

#Artificial intelligence (AI) #Evozyne #Funding #Generative AI #Investment

$81 million raised to advance generative AI for drug discovery

Evozyne has closed an $81 million Series B investment round that will fund the biotech’s generative AI-powered drug discovery platform and product development. “In its first three years, Evozyne proved it could deliver novel, high-performance proteins that solve critical problems in healthcare and sustainability. Our next three years will be… Read More

#Business & Investment #News

Quantum drug discovery
#Artificial intelligence (AI) #Drug design #Drug discovery #Enzymes #Funding #Kuano #Quantum computing

£1.8 million raised to accelerate quantum drug discovery 

Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, has raised £1.8M in seed funding, which will facilitate further validation of Kuano’s quantum simulation platform for the design of more effective drug candidates targeting enzymes, as well as continued company growth through… Read More

#Business & Investment #News

GBP pound sterling funding
#BDD Clinical Trials #Clinical trials #Funding

£2 million secured to fuel expansion in early phase clinical trials  

Integrated drug formulation and clinical trials company, BDD Clinical Trials, has secured a further round of investment for £2M to aid the company’s expansion in response to growing demand for both its patented drug delivery technology and specialist clinical trial services.  The latest investment package follows a strong 18 months… Read More

#Business & Investment #News

Business financing
#Apollo Therapeutics #Drug discovery #Funding

Apollo Therapeutics closes $226.5 million Series C financing 

Apollo Therapeutics, a biopharmaceutical company focused on translating fundamental medical research into medicines through a hub-and-spoke approach, has closed $226.5 million in a Series C financing, led by lead investor Patient Square Capital.  Financing significantly adds to the $195 million previously raised by the company, and to Apollo’s pipeline of… Read More

#Business & Investment #News